drude < drug < druggable

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by drug

Number of relevant bibliographic references: 235.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000004 (2020)	Yu-Shi Zhang [République populaire de Chine] ; Wei-Hong Cong [République populaire de Chine] ; Jing-Jing Zhang [République populaire de Chine] ; Fei-Fei Guo [République populaire de Chine] ; Hong-Mei Li [République populaire de Chine]	[Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].
000006 (2020)	J. Reina [Espagne]	[Remdesivir, the antiviral hope against SARS-CoV-2].
000009 (2020)	B. Du [République populaire de Chine] ; H B Qiu [République populaire de Chine] ; X. Zhan [République populaire de Chine] ; Y S Wang [République populaire de Chine] ; H Y J. Kang [République populaire de Chine] ; X Y Li [République populaire de Chine] ; F. Wang [République populaire de Chine] ; B. Sun [République populaire de Chine] ; Z H Tong [République populaire de Chine]	[Pharmacotherapeutics for the New Coronavirus Pneumonia].
000041 (2020)	Sean Ekins [Oman] ; Peter B. Madrid [États-Unis]	Tilorone: A Broad-Spectrum Antiviral For Emerging Viruses.
000064 (2020)	Sophie Alexandra Baron [France] ; Christian Devaux [France] ; Philippe Colson [France] ; Didier Raoult [France] ; Jean-Marc Rolain [France]	Teicoplanin: an alternative drug for the treatment of coronavirus COVID-19?
000065 (2020)	Aaron E L. Warren [Australie] ; Linda J. Dalic [Australie] ; Wesley Thevathasan [Australie] ; Annie Roten [Australie] ; Kristian J. Bulluss [Australie] ; John Archer [Australie]	Targeting the centromedian thalamic nucleus for deep brain stimulation.
000072 (2020)	Shan-Meng Lin [Taïwan] ; Shih-Chao Lin [États-Unis] ; Jia-Ning Hsu [Taïwan] ; Chung-Ke Chang [Taïwan] ; Ching-Ming Chien [Taïwan] ; Yong-Sheng Wang [Taïwan] ; Hung-Yi Wu [Taïwan] ; U-Ser Jeng [Taïwan] ; Kylene Kehn-Hall [États-Unis] ; Ming-Hon Hou [Taïwan]	Structure-Based Stabilization of Non-native Protein–Protein Interactions of Coronavirus Nucleocapsid Proteins in Antiviral Drug Design
000074 (2020)	Muhammad Tahir Ul Qamar [République populaire de Chine] ; Safar M. Alqahtani [Arabie saoudite] ; Mubarak A. Alamri [Arabie saoudite] ; Ling-Ling Chen [République populaire de Chine]	Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants†
000078 (2020)	Mahmoud Kandeel [Arabie saoudite] ; Mizuki Yamamoto [Japon] ; Abdulla Al-Taher [Arabie saoudite] ; Aya Watanabe [Japon] ; Kentaro Oh-Hashi [Japon] ; Byoung Kwon Park [Corée du Sud] ; Hyung-Joo Kwon [Corée du Sud] ; Jun-Ichiro Inoue [Japon] ; Mohammed Al-Nazawi [Arabie saoudite]	Small Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Fusion by Targeting Cavities on Heptad Repeat Trimers.
000110 (2020)	Junxiong Pang [Singapour] ; Min Xian Wang [Singapour] ; Ian Yi Han Ang ; Sharon Hui Xuan Tan ; Ruth Frances Lewis ; Jacinta I-Pei Chen ; Ramona A. Gutierrez ; Sylvia Xiao Wei Gwee [Singapour] ; Pearleen Ee Yong Chua [Singapour] ; Qian Yang ; Xian Yi Ng ; Rowena K. S. Yap ; Hao Yi Tan ; Yik Ying Teo ; Chorh Chuan Tan ; Alex R. Cook ; Jason Chin-Huat Yap ; Li Yang Hsu	Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review
000130 (2020)	Jahan S. Khalili [États-Unis] ; Hai Zhu [États-Unis] ; Nga Sze Amanda Mak [États-Unis] ; Yongqi Yan [États-Unis] ; Yi Zhu [États-Unis]	Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19.
000141 (2020)	Yushun Wan [États-Unis] ; Jian Shang [États-Unis] ; Shihui Sun [République populaire de Chine] ; Wanbo Tai [États-Unis] ; Jing Chen [République populaire de Chine] ; Qibin Geng [États-Unis] ; Lei He [République populaire de Chine] ; Yuehong Chen [République populaire de Chine] ; Jianming Wu [États-Unis] ; Zhengli Shi [République populaire de Chine] ; Yusen Zhou [République populaire de Chine] ; Lanying Du [États-Unis] ; Fang Li [États-Unis]	Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry.
000174 (2020)	Chantal M. Morel [Suisse] ; Olof Lindahl [Suède] ; Stephan Harbarth [Suisse] ; Marlieke E A. De Kraker [Suisse] ; Suzanne Edwards [Allemagne] ; Aidan Hollis [Canada]	Industry incentives and antibiotic resistance: an introduction to the antibiotic susceptibility bonus.
000175 (2020)	Bhumi Shah [Inde] ; Palmi Modi [Inde] ; Sneha R. Sagar [Inde]	In silico studies on therapeutic agents for COVID-19: Drug repurposing approach.
000186 (2020)	Ling Lin [République populaire de Chine] ; Lianfeng Lu [République populaire de Chine] ; Wei Cao [République populaire de Chine] ; Taisheng Li [République populaire de Chine]	Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.
000188 (2020)	Robert N. Kirchdoerfer [États-Unis]	Halting coronavirus polymerase.
000199 (2020)	Xu Qian [République populaire de Chine] ; Ran Ren [République populaire de Chine] ; Youfa Wang [République populaire de Chine] ; Yan Guo [République populaire de Chine] ; Jing Fang [République populaire de Chine] ; Zhong-Dao Wu [République populaire de Chine] ; Pei-Long Liu [République populaire de Chine] ; Tie-Ru Han [République populaire de Chine]	Fighting against the common enemy of COVID-19: a practice of building a community with a shared future for mankind
000218 (2020)	Manisha Prajapat ; Phulen Sarma ; Nishant Shekhar ; Pramod Avti ; Shweta Sinha ; Hardeep Kaur ; Subodh Kumar ; Anusuya Bhattacharyya ; Harish Kumar ; Seema Bansal ; Bikash Medhi	Drug targets for corona virus: A systematic review
000232 (2020)	Md Insiat Islam Rabby [Malaisie]	Current Drugs with Potential for Treatment of COVID-19: A Literature Review.
000233 (2020)	Youngchang Kim [États-Unis] ; Robert Jedrzejczak [États-Unis] ; Natalia I. Maltseva [États-Unis] ; Mateusz Wilamowski [États-Unis] ; Michael Endres [États-Unis] ; Adam Godzik [États-Unis] ; Karolina Michalska [États-Unis] ; Andrzej Joachimiak [États-Unis]	Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2.
000263 (2020)	Sheng-Qun Deng ; Hong-Juan Peng	Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "drug" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "drug" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    drug
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021